Back
Flotek Industries 10K Form
Buy
98
FTK
Flotek Industries
Last Price:
$14.43
Seasonality Move:
5.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | FTK/Flotek Industries Quarterly |
2023-11-08 | 10Q | FTK/Flotek Industries Quarterly |
2023-08-09 | 10Q | FTK/Flotek Industries Quarterly |
2023-05-11 | 10Q | FTK/Flotek Industries Quarterly |
2022-11-10 | 10Q | FTK/Flotek Industries Quarterly |
2022-08-11 | 10Q | FTK/Flotek Industries Quarterly |
Receive FTK News And Ratings
See the #1 stock for the next 7 days that we like better than FTK
FTK Financial Statistics
Sales & Book Value
Annual Sales: | $187M |
---|---|
Cash Flow: | $6.7M |
Price / Cash Flow: | 101.75 |
Annual Sales: | $4.01 |
Price / Book: | 3.57 |
Profitability
EPS (TTM): | 0.45000 |
---|---|
Net Income (TTM): | $14.3M |
Gross Margin: | $39.4M |
Return on Equity: | 12.95% |
Return on Assets: | 8.8% |
Flotek Industries Earnings Forecast
Key Flotek Industries Financial Ratios
-
The Gross Profit Margin over the past 27 years for FTK is 21.06%.
-
The Selling, General & Administrative Expenses for FTK have been equal to 13.21% of Gross Profit Margin.
-
The Research & Development expenses have been 0.92% of Revenue.
-
The Interest Expense is 10.43% of Operating Income.
-
The Net Earning history of FTK is 5.61% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 15 years.
Flotek Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | FTK |
CUSIP: | 343389 |
Website: | flotekind.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 2.19 |
Quick Ratio: | 1.8 |
Price-to-Earnings
Trailing P/E Ratio: | 42.18 |
---|---|
Forward P/E Ratio: | 17.07 |
FTK Technical Analysis vs Fundamental Analysis
Buy
98
Flotek Industries (FTK)
is a Buy
Is Flotek Industries a Buy or a Sell?
-
Flotek Industries stock is rated a BuyThe current Flotek Industries [FTK] share price is $14.34. The Score for FTK is 98, which is 96% above its historic median score of 50, and infers lower risk than normal.